LeMaitre Vascular, Inc. (LMAT)
Nasdaq: LMAT · Surgical & Medical Instruments & Apparatus · Burlington, MA · filing with the SEC since 2002
Grade6.9
◀ Past 7.6● Present 7.2▶ Future 6.0
Who owns LeMaitre Vascular, Inc.
As filed with the SECHolders of 5% or more
5
Blackrock, Inc. holds 13.8% of Common Stock, as its SCHEDULE 13G/A filed Apr 29, 2025 says.
Directors and officers
10
report now, of 14 people on the record since 2006. Their holdings as a group are not read here.
Institutions as a whole
n/a
The record does not read the share held by managers that file Form 13F, so none is printed and no split of the rest is estimated. What it holds is the 5 named at left.
Holders of 5% or moreshare of the class, as filed
Blackrock, Inc.
SCHEDULE 13G/A · filed Apr 29, 2025 · Common Stock · 17.4% in Feb 5, 2025
Conestoga Capital Advisors
SCHEDULE 13G/A · filed Jan 9, 2026 · Common Stock · 8.12% in Jan 10, 2025
George W. LeMaitre
SCHEDULE 13G/A · filed May 14, 2026 · Common Stock, $0.01 Par Value · 7.43% in Nov 12, 2025
Copeland Capital Management
SCHEDULE 13G · filed Jan 24, 2025 · Common Stock
First Trust Portfolios L.P.
SCHEDULE 13G · filed Jul 27, 2026 · Common
The Vanguard Group
SCHEDULE 13G/A · filed Mar 27, 2026 · Common Stock · reported falling below 5%
What LMAT reports owning in othersstakes of 5% or more, and other ties
21 subsidiaries in 16 countries, from the list filed with the 10-K filed Feb 26, 2026.
Insider tradesForm 4
11sales
0purchases
2sales on a scheduled plan
5people selling
$30.0Msold, in dollars
$0bought, in dollars
Open-market trades on Form 4 from Sep 30, 2025 to Sep 30, 2026. A scheduled plan is a selling program set in advance under SEC rule 10b5-1. The trades are listed as filed and do not feed the grade.
By calendar yearSoldBought
2026 runs to Sep 30, 2026. Dollars as filed, summed by the transaction date.
People who traded in the window5 of 14 on the roster
| Person | Role as filed | Sales | Sold | On a plan | Buys | Bought |
|---|---|---|---|---|---|---|
| Lemaitre George W | Chairman and CEO | 4 | $27.1M | 2 | 0 | $0 |
| Roberts David B | President and Director | 2 | $1.3M | 0 | 0 | $0 |
| Kamke Trent G | Senior V. P., Operations | 3 | $700,000 | 0 | 0 | $0 |
| Ross Bridget A | director | 1 | $600,000 | 0 | 0 | $0 |
| Jasinski Lawrence J | director | 1 | $400,000 | 0 | 0 | $0 |